Sevelamer
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Sevelamer and local guidelines before prescribing.
Phosphate binder
Mechanism
Non-calcium phosphate binder.
Uses
Hyperphosphataemia in CKD.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Constipation, nausea, abdominal pain.
Interactions
Reduces absorption of ciprofloxacin and levothyroxine.
Contraindications and cautions
Bowel obstruction
Monitoring
Phosphate, bicarbonate
Pregnancy and breastfeeding
Acceptable
Renal and hepatic impairment
Used in dialysis
Overdose and reversal
Supportive
Special advice
Take with meals; separate from interacting drugs.
More from the textbook: uses, cautions and other points
- Phosphate binders with meals. NICE suggests calcium acetate first-line in adults, and sevelamer or lanthanum if calcium-based binders are unsuitable.
Endocrinology: Bone Medicine - Sevelamer - calcium-free; GI upset; also lowers cholesterol.
Renal: Anatomy, Physiology and Pharmacology - Calcium acetate / sevelamer / lanthanum | Phosphate binders with meals; calcium load (calcium-based).
Renal: Anatomy, Physiology and Pharmacology - Sevelamer - non-calcium; if calcium is high or there is vascular calcification.
Renal: Chronic Kidney Disease - Sevelamer | Non-calcium phosphate binder; high calcium or vascular calcification.
Renal: Chronic Kidney Disease
Where it is discussed in the book
- Endocrinology: Bone Medicine (1 mention)
- Renal: Anatomy, Physiology and Pharmacology (2 mentions)
- Renal: Chronic Kidney Disease (2 mentions)